or
forgot password

Peripheral Blood and Skin Sample Collection for Cutaneous Lymphoma Research


N/A
18 Years
N/A
Open (Enrolling)
Both
Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides

Thank you

Trial Information

Peripheral Blood and Skin Sample Collection for Cutaneous Lymphoma Research


The purpose of this study is to provide a central mechanism for monitoring access to
peripheral blood and skin specimens obtained from CTCL patients to monitor:

- immunologic assays/flow cytometry

- tumor progression/regression

- genomic studies

- proteomic studies

- others germane to the advancement of CTCL treatment


Inclusion Criteria:



- 18 or older

- able and willing to provide informed consent

- diagnosed with CTCL

Exclusion Criteria:

- Lack of CTCL diagnosis in medical record

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Proteonomics of Cutaneous T-cell lymphoma

Outcome Description:

Proteonomic variables will be measured in blood and tissue of consented CTCL patients.

Outcome Time Frame:

Ongoing

Safety Issue:

No

Principal Investigator

Larisa J. Geskin, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Pittsburgh

Authority:

United States: Food and Drug Administration

Study ID:

0411029

NCT ID:

NCT00177268

Start Date:

October 2004

Completion Date:

January 2023

Related Keywords:

  • Cutaneous T-cell Lymphoma
  • Sezary Syndrome
  • Mycosis Fungoides
  • Cutaneous T-cell Lymphoma
  • Sezary Syndrome
  • Mycosis Fungoides
  • Blood/tissue banking
  • Lymphoma
  • Mycoses
  • Mycosis Fungoides
  • Sezary Syndrome
  • Lymphoma, T-Cell
  • Lymphoma, T-Cell, Cutaneous

Name

Location
University of Pittsburgh Medical Center Pittsburgh, Pennsylvania  15213